News | Lung Imaging | March 09, 2021

The new thresholds can save lives and aid health equity efforts

Final U.S. Preventive Services Task Force (USPSTF) recommendations to lower the initial age and smoking history requirements for lung cancer screening (LCS) reconfirm the lifesaving ability of these tests and present an opportunity for providers to re-engage screening age patients to save more lives.

Getty Images


March 9, 2021 — Final U.S. Preventive Services Task Force (USPSTFrecommendations to lower the initial age and smoking history requirements for lung cancer screening (LCS) reconfirm the lifesaving ability of these tests and present an opportunity for providers to re-engage screening age patients to save more lives.

The American College of Radiology (ACR) urges the Center for Medicare and Medicaid Services (CMS) to quickly update its LCS National Coverage Decision to reflect the USPSTF changes. This combined USPSTF and CMS action would enable the medical community to strike a blow against the nation’s leading cancer killer by using LCS screening to its full advantage.

Screening eligibility expansion should spur more providers to start conversations with eligible patients that can ease lung cancer outcomes disparities — particularly among women, Black men and those in rural areas

Annual lung cancer screening with low-dose computed tomography (LDCT) in high-risk patients significantly reduces lung cancer deaths. Sadly, less than 15% of Americans who met previous USPSTF lung cancer screening criteria are tested each year. Given that the American Cancer Society predicts 131,880 lung cancer deaths in 2021, more-widespread screening could save 30,000–60,000 lives in the United States each year.

“Lung cancer kills more people each year than breast, colon and prostate cancers combined. Particularly with the expanded screening thresholds implemented nationwide, this cost-effective test can save more lives than any cancer-screening test in history. I urge primary care providers and pulmonologists to use this new information to start screening conversations with their recommended patients today,” said Debra Dyer, M.D., FACR, Chair of the ACR Lung Cancer Screening Steering Committee.

The underuse of LCS may, in part, be due to a large overestimation of LCS false-positive rates, which inflates assumptions of potential harms. The false-positive rate in clinical LCS practices using Lung-RADS structured reporting is 7–8% — similar to screening mammography. It is critical that physicians are up-to-date on current information so they can engage with their patients to make informed screening decisions.

“The Affordable Care Act mandates that private insurers incorporate updated USPSTF guidelines into coverage within one year. The healthcare community and advocates must contact insurers to  get these changes implemented as soon as possible so that primary care providers and thoracic specialists can act on the lower starting age and more-inclusive pack-year threshold to order these scans for their high-risk patients,” said Ella Kazerooni M.D., MS, FACR, Chair of the ACR Lung-RADS committee and Lung Cancer Screening Registry.

For more CT lung cancer screening information: RadiologyInfo.orgNLCRT.org and ACR Lung Cancer Screening Resources.

 


Related Content

News | Artificial Intelligence

Sept. 13, 2024 — Bayer Calantic Digital Solutions has announced the availability of a new eBook that addresses how ...

Time September 12, 2024
arrow
News | Computed Tomography (CT)

SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...

Time August 06, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 30, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
News | Artificial Intelligence

July 26, 2024 — GE HealthCare and Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company, announced a strategic ...

Time July 26, 2024
arrow
Feature | Radiology Business | By Christine Book

Across the healthcare industry, and, notably, throughout the radiology community in just the past few years, the focus ...

Time July 26, 2024
arrow
Feature | Mobile C-Arms | By Melinda Taschetta-Millane

Mobile C-arms continue to revolutionize medical imaging, offering versatility, mobility and real-time visualization ...

Time July 26, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
Subscribe Now